Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $23,015 | 7 | 89.4% |
| Unspecified | $1,400 | 1 | 5.4% |
| Travel and Lodging | $831.87 | 4 | 3.2% |
| Food and Beverage | $397.55 | 4 | 1.5% |
| Education | $99.00 | 1 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharma AG | $17,480 | 6 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $6,614 | 8 | $0 (2019) |
| PFIZER INC. | $1,400 | 1 | $0 (2021) |
| SOBI, INC | $249.00 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $249.00 | 2 | SOBI, INC ($249.00) |
| 2021 | $8,470 | 3 | Novartis Pharma AG ($7,070) |
| 2019 | $9,644 | 9 | Novartis Pharmaceuticals Corporation ($6,614) |
| 2018 | $3,030 | 1 | Novartis Pharma AG ($3,030) |
| 2017 | $4,350 | 2 | Novartis Pharma AG ($4,350) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | SOBI, INC | GAMIFANT (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: HEMATOLOGY | ||||||
| 11/15/2024 | SOBI, INC | Gamifant (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Hematology | ||||||
| 11/23/2021 | Novartis Pharma AG | ILARIS (Biological) | Consulting Fee | Cash or cash equivalent | $3,535.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/10/2021 | PFIZER INC. | XELJANZ (Drug) | — | In-kind items and services | $1,400.00 | Research |
| Study: TOFACITINIB CLINICAL PUBLICATION PROGRAM • Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/12/2021 | Novartis Pharma AG | ILARIS (Biological) | Consulting Fee | Cash or cash equivalent | $3,535.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2019 | Novartis Pharma AG | ACZ885G_ILARIS_IMMUNOLOGY (Biological) | Consulting Fee | Cash or cash equivalent | $3,030.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2019 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Consulting Fee | Cash or cash equivalent | $5,535.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2019 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Travel and Lodging | Cash or cash equivalent | $289.24 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2019 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Travel and Lodging | In-kind items and services | $162.63 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2019 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Food and Beverage | In-kind items and services | $120.77 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2019 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Travel and Lodging | Cash or cash equivalent | $28.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2019 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Food and Beverage | Cash or cash equivalent | $7.33 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2019 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Travel and Lodging | In-kind items and services | $352.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2019 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Food and Beverage | In-kind items and services | $119.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2018 | Novartis Pharma AG | ACZ885G (Biological) | Consulting Fee | Cash or cash equivalent | $3,030.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2017 | Novartis Pharma AG | ACZ885G (Biological) | Consulting Fee | Cash or cash equivalent | $1,740.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2017 | Novartis Pharma AG | ACZ885G (Biological) | Consulting Fee | Cash or cash equivalent | $2,610.00 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TOFACITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,400 | 1 |
About Dr. Sampath Prahalad, MD
Dr. Sampath Prahalad, MD is a Pediatric Rheumatology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548349012.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sampath Prahalad, MD has received a total of $25,743 in payments from pharmaceutical and medical device companies, with $249.00 received in 2024. These payments were reported across 17 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($23,015).
Practice Information
- Specialty Pediatric Rheumatology
- Location Atlanta, GA
- Active Since 11/03/2006
- Last Updated 02/27/2024
- Taxonomy Code 2080P0216X
- Entity Type Individual
- NPI Number 1548349012
Products in Payments
- ILARIS (Biological) $13,684
- ACZ885G (Biological) $7,380
- ACZ885G_ILARIS_IMMUNOLOGY (Biological) $3,030
- XELJANZ (Drug) $1,400
- Gamifant (Drug) $150.00
- GAMIFANT (Drug) $99.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Rheumatology Doctors in Atlanta
Baruch Goldberg, Md, MD
Pediatric Rheumatology — Payments: $241.61
Dr. Cynthia Manos, M.d, M.D
Pediatric Rheumatology — Payments: $191.67
Angela Taneja, Md, MD
Pediatric Rheumatology — Payments: $120.69
Kelly Rouster-Stevens, Md, Pharmd, MD, PHARMD
Pediatric Rheumatology
Larry Vogler, Md, MD
Pediatric Rheumatology
Elaine Flanagan, Md, MD
Pediatric Rheumatology